Should FDG PET/CT be used for the initial staging of breast cancer?
Groheux
David
D
Department of Nuclear Medicine, Hôpital Saint-Louis, Assistance publique-Hopitaux de Paris, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France.
Hindié
Elif
E
Rubello
Domenico
D
Espié
Marc
M
Baillet
Georges
G
Giacchetti
Sylvie
S
Misset
Jean-Louis
JL
Moretti
Jean-Luc
JL
D001365:Axilla; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008197:Lymph Node Excision; D009362:Neoplasm Metastasis / Q000175:diagnosis / Q000000981:diagnostic imaging; D009367:Neoplasm Staging / Q000379:methods; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D021701:Sentinel Lymph Node Biopsy; D014057:Tomography, X-Ray Computed
D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18